Trials / Completed
CompletedNCT00947076
To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg
A Comparative Bioavailability Study of Fluoxetine Hydrochloride Capsules, 40 mg
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of fluoxetine hydrochloride capsules, 40 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluoxetine Hydrochloride Capsules, 40 mg (Geneva Pharmaceutical, Inc) | |
| DRUG | Fluoxetine Hydrochloride Capsules, 40 mg (Prozac) (Eli Lilly) |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2001-04-01
- Completion
- 2001-04-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00947076. Inclusion in this directory is not an endorsement.